Bausch Health Companies Inc.
BHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10 | $9 | $8 | $8 |
| % Growth | 9.9% | 7.8% | -3.7% | – |
| Cost of Goods Sold | $3 | $3 | $2 | $2 |
| Gross Profit | $7 | $6 | $6 | $6 |
| % Margin | 71.1% | 70.8% | 70.9% | 71.6% |
| R&D Expenses | $1 | $1 | $1 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $3 | $3 | $3 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $1 | $2 | $2 | $3 |
| Operating Expenses | $5 | $5 | $5 | $6 |
| Operating Income | $2 | $1 | $0 | $0 |
| % Margin | 16.1% | 11% | 5.6% | 5.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | $0 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$0 | -$1 | -$0 | -$1 |
| % Margin | -0.5% | -6.8% | -2.8% | -11.2% |
| EPS | -0.13 | -1.62 | -0.59 | -2.61 |
| % Growth | 92% | -174.6% | 77.4% | – |
| EPS Diluted | -0.13 | -1.62 | -0.59 | -2.61 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $2 |
| EBITDA | $3 | $3 | $3 | $3 |
| % Margin | 32.6% | 32.9% | 35.4% | 38.7% |